Twist biosciences stock.

SOUTH SAN FRANCISCO, Calif., February 28, 2023--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its ...The Twist Bioscience Corp. stock price fell by -1.88% on the last day (Thursday, 30th Nov 2023) from $24.51 to $24.05. During the last trading day the stock fluctuated 5.28% from a day low at $23.86 to a day high of $25.12. The price has been going up and down for this period, and there has been a 20.85% gain for the last 2 weeks.The biggest reason why Twist is currently valued at $1.9 billion is the potential to use their silicon DNA synthesis platform for the discovery of new drugs.Twist Bioscience Corp stock performance at a glance. Check Twist Bioscience Corp’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. TWST Stock Performance. USD USD; Previous close: 19.07: 19.07: Day range: 20.59 - 24.8820.59 - 24.88Year range: 11 - 3111 - 31

Twist Bioscience Corp Stock Price History. Twist Bioscience Corp’s ( TWST) price is currently down 18.71% so far this month. During the month of March, Twist Bioscience Corp’s stock price has reached a high of $19.65 and a low of $14.98. Over the last year, Twist Bioscience Corp has hit prices as high as $58.76 and as low as $14.98.Dec 1, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Twist Bioscience stock is Moderate Buy based on the current 1 hold rating and 4 buy ratings for TWST. The average twelve-month price prediction for Twist Bioscience is $28.17 with a high price target of $36.00 and a low price target of $20.00. Twist Bioscience sees potential growth in 2024 with new products and resolved business issues. ... There is a high likelihood that Twist's stock moves significantly higher ahead of these events ...

Funding, Valuation & Revenue. Twist Bioscience has raised $295.86M over 14 rounds. Twist Bioscience's latest funding round was a IPO for $70M on October 31, 2018. Twist Bioscience's valuation in May 2017 was $405.5M. Twist Bioscience's latest post-money valuation is from October 2018.

Percent of Float. 27.22%. Overview. Complete Twist Bioscience Corp. stock information by Barron's. View real-time TWST stock price and news, along with industry-best analysis.1 thg 5, 2023 ... ... Stock https://finviz.com/?a=539622444 Protect Your Computer Data: Get ‍♂️ ... I found a reason to buy Ginkgo Bio - What do you guys think?Twist reported its fiscal Q3 results on August 5th with a net loss of $60.5 million or -$1.08 per share, compared to a loss of $40 million loss in the period last year.Shares of Twist Bioscience Corp. TWST, +3.64% plunged 18.7% in premarket trading on Tuesday after Scorpion Capital, an activist short seller, described the company as a "cash-burning inferno" and ...Before we jump into Twist Bioscience Corp’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background. Twist Bioscience Corporation is a synthetic biology and genomics company. The Company has developed a Twist Bioscience DNA synthesis platform to industrialize the engineering of biology.

Twist Bioscience has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, SpringWorks Therapeutics has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500.

5 brokers have issued 1-year target prices for Twist Bioscience's shares. Their TWST share price targets range from $20.00 to $36.00. On average, they predict the company's share price to reach $28.17 in the next twelve months. This suggests a possible upside of 15.0% from the stock's current price.

In the previous week, CareDx had 2 more articles in the media than Twist Bioscience. MarketBeat recorded 3 mentions for CareDx and 1 mentions for Twist Bioscience. Twist Bioscience's average media sentiment score of 1.87 beat CareDx's score of 1.44 indicating that Twist Bioscience is being referred to more favorably in the …Twist Bioscience appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings ...Stock Quote. Change Volume Today's Open Previous Close. Today's High Today's Low 52 Week High 52 Week Low. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. ... Twist Bioscience HQ 681 Gateway Blvd South San Francisco, CA 94080. Footer. Latest. Contact Us; FAQ; Get In Touch. Twitter;Stock Quote. Change Volume Today's Open Previous Close. Today's High Today's Low 52 Week High 52 Week Low. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. ... Twist Bioscience HQ 681 Gateway Blvd South San Francisco, CA 94080. Footer. Latest. Contact Us; FAQ; Get In Touch. Twitter;Twist Bioscience (NASDAQ: TWST) $23.81 (0.4%) $0.10 Price as of November 22, 2023, 4:00 p.m. ET Overview Financial Health Earnings Transcripts Related Stocks Key Data …Driving the innovation fund higher this month were biotech names CRISPR Therapeutics and Twist Bioscience, along with Roku, Coinbase, Block and Shopify, …

See the company profile for Twist Bioscience Corporation (TWST) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives ...Twist Bioscience's 'factory of the future' is up and running, despite rumors to the contrary. expand. ... Twist’s stock price fell $7.57 per share, or nearly 20%, to close at $30.43.Transcript : Twist Bioscience Corporation, Q4 2023 Earnings Call, Nov 17, 2023. Nov. 17. CI. Earnings Flash (TWST) TWIST BIOSCIENCE CORPORATION Posts Q4 Revenue $66.9M, vs. Street Est of $63.5M. Nov. 17. MT. Twist Bioscience Corporation Provides Revenue Guidance for the First Quarter, Fourth Quarter and Full Fiscal Year of 2024. Nov. 17.Twist Bioscience Corp’s trailing 12-month revenue is $245.1 million with a -83.5% profit margin. Year-over-year quarterly sales growth most recently was 16.8%. Analysts expect adjusted earnings to reach $-2.957 per share for the current fiscal year. Twist Bioscience Corp does not currently pay a dividend.About TWST. Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by …Twist Bioscience Reports Fiscal First Quarter 2023 Financial Results. – Revenue of $54.2M in 1QFY23 increased 29% over $42.0M in 1QFY22 –. – Orders increased to $64.7M in 1QFY23, an increase of 30% over 1QFY22 –. SOUTH SAN FRANCISCO, Calif. -- (BUSINESS WIRE)--Feb. 3, 2023-- Twist Bioscience Corporation …

Twist Bioscience Corp. historical stock charts and prices, analyst ratings, financials, and today’s real-time TWST stock price. Land. USA. TWIST BIOSCIENCE AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Twist Bioscience Corporation Registered Shs | A2N7L2 | TWST | US90184D1000.

A day after synthetic biology and genomics company Twist Bioscience ( TWST -5.04%) saw its shares rise 16.1%, they did a U-turn, falling 19.92% on Tuesday. The stock nearly matched its 52-week low ...The upgrade of Twist Bioscience to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.February 3, 2023 at 12:43 PM · 1 min read. Shares of Twist Bioscience Corp (NASDAQ: TWST) fell after the firm issued fiscal second-quarter revenue guidance that fell below the consensus Wall ...msn.com - November 2 at 8:14 PM. Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing. finance.yahoo.com - October 31 at 9:50 AM. Twist Bioscience (NASDAQ:TWST shareholders incur further losses as stock declines 9.8% this week, taking three-year losses to 80%.TWIST BIOSCIENCE CORPORATION (TWST) 24.01. at close. +4.94 (‎ +25.90%) after hours • as of Nov 17, 07:56 PM EST. 24.42. +0.41 (‎ +1.71%) 1D. 5D.25 thg 5, 2022 ... Writing the Future of Cell Therapies · Artificial Intelligence in Drug Discovery & Development · Twist Bioscience at Antibody Engineering and ...Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and IMIDomics, Inc., a patient ...

SOUTH SAN FRANCISCO, Calif., November 15, 2022--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its ...

Twist Bioscience (NASDAQ: TWST) operates as a biotechnology company. Use the CB Insights Platform to explore Twist Bioscience's full profile. ... Stock based compensation of approximately $58 to 60 million Depreciation and amortization of approximately $40 million DNA data storage spend of approximately $37 to $39 million …

Figure 9: Twist Gross Profit Margins (source: Created by author using data from Twist Bioscience) Twist expects their core business to achieve adjusted EBITDA breakeven at 300 million USD revenue.The share float percentage for the stock currently stands at 110.57%. There are 108.82% institutions holding the Twist Bioscience Corp stock share, with Blackrock Inc. the top institutional holder. As of Jun 29, 2023, the company held 12.03% of the shares, roughly 6.91 million TWST shares worth $141.28 million.Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Stock Quote/Chart Stock Quote. Change Volume Today's Open Previous Close. Today's High Today's Low ... Twist Bioscience HQ 681 Gateway Blvd South San Francisco, CA ... Unleash the Power of the Platform. Twist Bioscience developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a high-throughput silicon platform that allows us to miniaturize the chemistry necessary for DNA synthesis. This translates into time and cost savings for our customers across their workflows.SOUTH SAN FRANCISCO, Calif., June 20, 2023--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its ...Stock Quote/Chart Stock Quote. Change Volume Today's Open Previous Close. Today's High Today's Low ... Twist Bioscience HQ 681 Gateway Blvd South San Francisco, CA ... Land. USA. TWIST BIOSCIENCE AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Twist Bioscience Corporation Registered Shs | A2N7L2 | TWST | US90184D1000.The stock of Twist Bioscience Corporation has declined more than 60% since our first peek at it in the fall of last year. However, the stock saw its first insider buy in a year last week, and the ...Stock Price Forecast The 9 analysts offering 12-month price forecasts for Twist Bioscience Corp have a median target of 27.00, with a high estimate of 33.00 and a low estimate of 19.00.

Aug 13, 2020 · Why Twist Bioscience Stock Is Crashing This Week. 524%. Premium Investing Services. Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool ... Jan 2, 2022 · In this Motley Fool Live video recorded on Dec. 15, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss why Twist Bioscience's stock could be a 10-bagger. 10 stocks we like ... The latest price target for . Twist Bioscience (NASDAQ: TWST) was reported by Berenberg on Wednesday, September 27, 2023.The analyst firm set a price target for 27.00 expecting TWST to rise to ...Instagram:https://instagram. arm ipo prospectussprint t mobilefuturefuelfree otc trading Stock Quote. Change Volume Today's Open Previous Close. Today's High Today's Low 52 Week High 52 Week Low. Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes …1. Twist Bioscience. Twist has a proprietary method for manufacturing synthetic DNA. It's able to write more than 1 million short pieces of DNA on each silicon chip. By housing 10,000 times more ... poe chartroman cresto 3. Twist Biosciences. ARK Innovation ETF has bought more shares of Twist Biosciences (TWST 2.83%) as well over the last month. Twist is now the No. 21 position in that ETF and the No. 22 position ... nasdaq e mini Stock Price Forecast The 9 analysts offering 12-month price forecasts for Twist Bioscience Corp have a median target of 27.00, with a high estimate of 33.00 and a low estimate of 19.00.TWIST BIOSCIENCE CORPORATION (TWST) 24.01. at close. +4.94 (‎ +25.90%) after hours • as of Nov 17, 07:56 PM EST. 24.42. +0.41 (‎ +1.71%) 1D. 5D.